CDI Adult MDC 12 - Male Reproductive System Flashcards
Benign Hypertrophy of the Prostate
* Definition
* Clinical Indicators
* Treatment
- An overgrowth of prostate tissue experienced by nearly all men, often causing variable degrees of urinary outlet obstruction.
- Clinical indicators – frequency, urgency, nocturia, hematuria, frequent infections, elevated PSA.
- Treatment requires surgical intervention (TURP).
Diagnostics: The diagnostic marker of BPH in most patients is an elevated PSA. PSA is moderately elevated in 30-50% of patients.
BPH and Lower Urinary Tract
* When assigning the patient’s BPH Diagnosis, what are the 2 options to choose from?
* What are considered lower urinary tract symptoms?
- When you assign the patient’s BPH diagnosis, you will have 2 options: with or without lower urinary tract symptoms.
N40.0 Prostate
N40.1 with lower urinary tract symptoms
N40.0 without lower urinary tract symptoms
What is considered a “lower urinary tract symptom”:
incomplete bladder emptying
nocturia
straining on urination
urinary frequency
urinary hesitancy
urinary incontinence
urinary obstruction
urinary retention
urinary urgency
weak urinary stream
There are several conditions considered under the broad heading of lower urinary tract symptom, such as nocturia, frequency, hesitancy, retention, and urgency. Assign your patient’s condition best supported by the medical record documentation. However, if there is clinical evidence of a condition, such as frequency, but it is not adequately documented in the medical record, seek clarification from the physician.
BPH Complications
As the urethra becomes compromised, secondary complications occur:
- calculi formation (from urinary stasis)
- hydronephrosis (d/t bladder neck obstruction)
- acute renal failure (d/t bladder neck obstruction)
If there is clinical evidence of one of these conditions but it is not documented, ask a question.
BPH and Acute Renal Failure
If the condition is present on admission with BPH and meets the definition of principal diagnosis, assign acute renal failure as the principal diagnosis.
- A principal diagnosis of acute kidney injury (AKI) would more accurately reflect severity of illness and risk of mortality and level of care requirement, more so than a principal diagnosis of chronic BPH.
If necessary, seek clarification of the condition, POA status, or both.
Acute renal failure due to blockage from an enlarged prostate is not uncommon in the BPH patient. The physician’s documentation will need to clearly link the ARF/AKI to the BPH.
Acute Renal Failure/Acute Kidney Injury
An abrupt decline in renal function, clinically manifesting as a reversible acute increase in nitrogen waste products—measured by blood urea nitrogen (BUN) and serum creatinine levels—over the course of hours to weeks.
RIFLE establishes criteria according to creatinine levels, GFR, and urinary output for risk, injury, failure, loss of function and end-stage renal disease. Other classification systems include AKIN and KDIGO.
Documentation Validation
Clarification Example
Clinical Scenario: A 53 yo male was directly admitted from the physician’s office late yesterday afternoon with a diagnosis of “BPH.” His chemistry level drawn on admission reflected a creatinine of 3.7. He does not have a history of CKD. He also complained of weakness and feeling shaky along with a minimal urine stream. His treatment regimen includes an IVF bolus followed by IVFs at 125 cc/hr, repeat BUN and creatinine level q4 hours, strict I&O, and pending urology and surgical consults.
Acute Renal Failure and BPH
Clarification Example
* Acute renal failure, POA due to BPH requiring treatment with IV fluid resuscitation
* Other; with explanation of the clinical findings
* Unable to determine (no explanation for the clinical findings)
The medical record reflects the following clinical evidence:
Clinical Indicators: weakness and a creatinine level of 3.7, minimal urine stream
Risk Factor: BPH
Treatment: fluid resuscitation, serial labs, I&O, urology/surgery consults
TURP
* Generally performed for what condition?
* Complications include?
* The TURP assignment is dependent on what?
* What Root Operation is used to index this procedure?
- Generally performed for moderate to severe urinary flow obstruction due to overgrowth of prostate tissue (BPH).
- Complications: Post-op urinary retention, cath-rel UTI, ABLA, incontinence, post-op hyponatremia.
- The assignment of TURP is dependent on principal diagnosis.
- Root Operation = Excision
Excision Cutting out/off, without replacement, a portion of a body part
During a TURP the surgeon excises excess (hypertrophied) prostate tissue. Use the root operation EXCISION to index the procedure
TURP, as a surgical DRG assignment, is available in multiple MDCs. If necessary, clarify the patient’s diagnosis with the physician.
TURP Secondary Diagnosis: Acute Blood Loss Anemia
You are not allowed to assume a diagnosis of acute blood loss anemia from a diagnosis of “blood loss anemia” – the physician must provide explicit documentation of the condition.
- Acute blood loss anemia (acute post hemorrhagic anemia) is a condition in which a person quickly loses a large volume of circulating hemoglobin. The condition is usually associated with an incident of trauma, but it can also occur during or after a surgical procedure.
There is no specific lab value or parameter used to identify acute blood loss anemia as each lab has their own facility-specific values. However, a low H&H, serial monitoring of the H&H or blood transfusion may be a clinical clue of what the physician may be thinking and treating, but not documenting.
Urolift - Coding Clinic 4Q2013, p123
Question: Provider documentation states rigid cystoscopy, transurethral placement of four transprostatic permanent retraction devices utilizing the UroLift System to treat benign localized hyperplasia of prostate with urinary obstruction and other lower urinary tract symptoms.
What is the correct ICD-10-PCS code assignment for this procedure?
Coding Clinic Advice
Answer:
Assign the following ICD-10-PCS code for this procedure utilizing the UroLift System:
0T7D8DZ Dilation of urethra with intraluminal device, via natural or artificial opening endoscopic
The UroLift System is utilized to treat lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). This minimally invasive technology is designed to open the urethra by moving back the obstructing prostatic lobes. This is done without incisions, resection or thermal injury to the prostate.
Explanation:For some BPH patients, a Urolift procedure may be the treatment of choice instead of a TURP. It is a minimally invasive procedure during which the surgeon endoscopically dilates the urethra with a series of strategically placed stents. The root operation used for this procedure is dilation rather than excision.
Infection and Sepsis
- If a diagnosis of sepsis is validated as present on admission, assign sepsis as the principal diagnosis.
- If sepsis develops after the time of admission, assign sepsis as a secondary diagnosis.
SIRS may be clinically indicated by any 2 of the 4 following indicators in the presence of an infectious process:
― Temperature > 38°C or < 36°C
― Heart rate > 90/min
― Respiratory rate > 20/min or PaCO2 < 32 mmHg
― WBC > 12,000/mm3 or < 4000/mm3 or > 10% immature bands
If the clinical evidence supports sepsis, seek clarification from the physician.
sepsis documentation sample clarification
Sample Clarification
Scenario: A 34 yo male presents to the ED with complaints of low pelvic pain, difficult urination, fever and increasing lethargy x5 days. Triage VS are noted as: T102.4, P102, R22, BP 112/68. Stat blood work reveals a WBC at 25.6 with 12% bandemia. He is admitted to ICU with a diagnosis of “acute prostatitis with bandemia.” His treatment regimen includes IV vancomycin.
Documentation Management
Sample Clarification:
* Sepsis, POA due to acute prostatitis requiring admission to ICU and treatment with IV vancomycin
* Other; with explanation of the clinical findings
* Unable to determine (no explanation for the clinical findings)
The medical record reflects the following clinical evidence:
Clinical Indicators: T102.4, P102, R22, WBC 25.6, 12% bandemia, increasing lethargy
Risk Factor: delayed treatment for acute prostatitis
Treatment: ICU admission, IV vancomycin
Explanation:A 34-year-old male was admitted with acute prostatitis and bandemia. But the review of the clinical presentation reveals a temp of 102.4, p102, r22, an elevated WBC at 25.6 and 12% bands. He’s been admitted to ICU and is receiving IV vancomycin.
His clinical presentation seems a bit more systemic than a localized infection. Here’s what we’ll ask the physician: sepsis, present on admission, due to acute prostatitis requiring admission to ICU and IV vancomycin.
Prostate Cancer
* Clinical Indicators
* Risk Factors
* Treatment
- One of the most common types of cancer in men.
- Clinical indicators - dysuria, decreased urinary stream, blood in the semen, pelvic pain, bone pain and erectile dysfunction.
- Risk factors include advancing age, obesity, a family history, and race (African American).
- Treatment requires surgical intervention, chemo and/or radiation.
Stages of Prostate Cancer
- Stage I: very early stage; cancer confined to a small area of the prostate
- Stage II: cancer cells not confined to a small area of the prostate; may involve both sides of the prostate
- Stage III: cancer cells have spread from the prostate to the seminal vesicles or other tissue within close proximity of the prostate
- Stage IV: metastatic disease with invasion of the cancer into other organs such as the lymph nodes, bones, lungs, bladder